logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Akira Ooki

Department of Gastroenterological Chemotherapy
H指数:26
被引数:2,108

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study

日本接受 fruquintinib 治疗的转移性结直肠癌患者中，蛋白尿作为早期剂量调整的原因：一项多中心真实世界研究

International Journal of Clinical Oncology
IF2.8
2026-08-270
OAAI
Shohei Udagawa; Chihiro Ishizuka; Hiroki Osumi; Toshiharu Hirose; Natsuko Okita; Hidekazu Hirano; Hirokazu Shoji; Ken Kato; Koichiro Yoshino; Keitaro Shimozaki; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Akira Ooki; Keisho Chin; Kensei Yamaguchi; Atsuo Takashima; Eiji Shinozaki
Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

HER2阳性晚期胃癌患者真实世界中的治疗选择增加和生存改善（2011年至2023年）

Therapeutic Advances in Gastroenterology
IF3.4
2026-04-110
PRE
Keitaro Shimozaki; Akira Ooki; Kaoru Yoshikawa; Koichiro Yoshino; Shohei Udagawa; Hiroki Osumi; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Daisuke Takahari; Eiji Shinozaki; Keisho Chin; Kensei Yamaguchi
Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience

Zolbetuximab联合化疗在Claudin 18亚型2阳性晚期胃癌中的安全性与有效性：真实世界经验的初步报告

Journal of Cancer Research and Clinical Oncology
IF2.8
2025-12-180
OAAI
Keitaro Shimozaki; Akira Ooki; Shota Fukuoka; Hiroki Osumi; Kaoru Yoshikawa; Koichiro Yoshino; Shohei Udagawa; Takeru Wakatsuki; Eiji Shinozaki; Mariko Ogura; Keisho Chin; Kensei Yamaguchi
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort

糖皮质激素在粒细胞集落刺激因子相关大血管血管炎中很少需要：日本癌症中心队列

RHEUMATOLOGY
IF4.4
2025-12-010
PRE
Morita, Yuka; Takeda, Koichi; Osumi, Hiroki; Aoyama, Yosuke; Fukuda, Naoki; Shimozaki, Keitaro; Udagawa, Shohei; Fukuoka, Shota; Ogura, Mariko; Wakatsuki, Takeru; Ooki, Akira; Chin, Keisho; Shinozaki, Eiji; Takano, Toshimi; Shiga, Taro; Yamaguchi, Kensei
Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

循环肿瘤DNA在HER2阳性晚期胃癌中的临床意义：一项关于HER2和PD-1双靶向疗法（Ni-High）的 Ib 期临床试验的协作研究

Therapeutic Advances in Medical Oncology
IF4.2
2025-09-120
OA
Hiroki Osumi; Takeru Wakatsuki; Akira Ooki; Keisho Chin; Hirokazu Shoji; Mariko Ogura; Izuma Nakayama; Noriko Yamamoto; Hidekazu Hirano; Hiroki Hara; Keiko Minashi; Eiji Shinozaki; Ken Kato; Naoki Ishizuka; Shigehisa Kitano; Kengo Takeuchi; Narikazu Boku; Kensei Yamaguchi; Daisuke Takahari
Effect of pretreatment vascular endothelial growth factor inhibitor use on the safety and efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer

使用术前血管内皮生长因子抑制剂的既往用药对三氟尿idine/替吡拉塞联合贝伐珠单抗在转移性结直肠癌患者中安全性与有效性的影响

international journal of oncology
IF2.8
2025-07-210
PRE
Koshiro Fukuda; Hiroki Osumi; Akira Ooki; Daisaku Kamiimabeppu; Shohei Udagawa; Shota Fukuoka; Mariko Ogura; Takeru Wakatsuki; Keisho Chin; Mitsuhiro Fujishiro; Kensei Yamaguchi; Eiji Shinozaki
A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study

一项多中心、随机、开放标签的2期研究，旨在探讨接受trastuzumab deruxtecan治疗的晚期/复发性胃癌患者的最佳止吐疗法：EN-hance研究

international journal of oncology
IF2.8
2025-04-280
OA
Aoyama, Toru; Ooki, Akira; Oba, Koji; Nishikawa, Kazuhiro; Kawabata, Ryohei; Honda, Michitaka; Maeda, Hiromichi; Kanda, Mitsuro; Sugiyama, Keiji; Makiyama, Akitaka; Segami, Kenki; Takahashi, Masazumi; Shindo, Yoshiaki; Namikawa, Tsutomu; Oshima, Takashi; Katayama, Aya; Shiosakai, Kazuhito; Sakamoto, Junichi
Impact of early tumor shrinkage on survival outcomes in patients with HER2-positive advanced gastric cancer treated with trastuzumab deruxtecan in third- or later-line settings

早期肿瘤缩小对接受曲妥珠单抗德鲁替康治疗的三线或更后线治疗的HER2阳性晚期胃癌患者生存结局的影响

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
IF3.4
2025-04-240
OA
Koshiro Fukuda; Hiroki Osumi; Keitaro Shimozaki; Keisho Chin; Mariko Ogura; Shota Fukuoka; Shohei Udagawa; Koichiro Yoshino; Mikako Tamba; Takeru Wakatsuki; Eiji Shinozaki; Kensei Yamaguchi; Akira Ooki
Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma

多西他赛、顺铂和5-氟尿嘧啶新辅助治疗局部晚期食管鳞状细胞癌的真实世界安全性和有效性

BMC CANCER
IF3.4
2025-04-080
OAAI
Tamba, Mikako; Osumi, Hiroki; Ogura, Mariko; Fukuoka, Shota; Okamura, Akihiko; Kanamori, Jun; Imamura, Yu; Yoshino, Koichiro; Udagawa, Shohei; Wakatsuki, Takeru; Shinozaki, Eiji; Watanabe, Masayuki; Yamaguchi, Kensei; Chin, Keisho; Ooki, Akira
Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

调查2011年至2023年间免疫疗法在HER2阴性晚期胃癌真实世界患者中的作用

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-02-240
OA
Keitaro Shimozaki; Akira Ooki; Koichiro Yoshino; Mikako Tamba; Shohei Udagawa; Hiroki Osumi; Shota Fukuoka; Izuma Nakayama; Takeru Wakatsuki; Mariko Ogura; Daisuke Takahari; Eiji Shinozaki; Keisho Chin; Kensei Yamaguchi
Interim endoscopic restaging after induction chemotherapy to predict complete response and survival after total neoadjuvant therapy in low rectal cancer: Ad-hoc analysis of the IMPACT trial

诱导化疗后内镜分期以预测低位直肠癌完全新辅助治疗后的完全应答和生存：IMPACT试验的专项分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Shinozaki, E.; Osumi, H.; Chino, A.; Akiyoshi, T.; Taguchi, S.; Ooki, A.; Udagawa, S.; Fukuoka, S.; Wakatsuki, T.; Ogura, M.; Chin, K.; Matsui, S.; Mukai, T.; Yamaguchi, T.; Miyazaki, N.; Fukunaga, Y.; Yamaguchi, K.; Konishi, T.

研究方向

暂未获取到该数据
K
Kensei Yamaguchi
H 指数:65论文数:921被引数:2.2万
H
Hiroki Osumi
H 指数:20论文数:189被引数:1,585
T
Takeru Wakatsuki
H 指数:24论文数:371被引数:2,541
M
Mariko Ogura
H 指数:19论文数:208被引数:1,563
E
Eiji Shinozaki
H 指数:29论文数:345被引数:3,472
K
Keisho Chìn
H 指数:41论文数:329被引数:1.1万
I
Izuma Nakayama
H 指数:18论文数:212被引数:1,723
K
Keitaro Shimozaki
H 指数:12论文数:95被引数:456
D
Daisuke Takahari
H 指数:32论文数:355被引数:4,589
S
Shota Fukuoka
H 指数:21论文数:176被引数:4,845